Latest related prices for venetoclax/venetoclax in 2024

Venetoclax/Venetoclax is an antineoplastic agent (cancer drug) that interferes with the growth of cancer cells, which are eventually destroyed by the body. Venetoclax is indicated for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, in patients who have received at least one prior therapy. It is also used with obinutuzumab to treat previously untreated CLL or SLL.

Venetoclax is also used with other drugs (such as azacitidine, decitabine, low-dose cytarabine) to treat adults 75 years and older with newly diagnosed acute myeloid leukemia (AML) or who have other conditions that prevent the use of standard chemotherapy. Venetoclax is only available with a doctor's prescription.

The original drug of Venacla is now on the market in China, providing patients with a variety of specifications to choose from. The price of this drug varies according to different specifications, and is roughly in the range of RMB 1,000 to RMB 4,000 per box. It is gratifying that venetoclax has been included in Category B medical insurance, but it should be noted that medical insurance reimbursement is mainly applicable to patients diagnosed with adult acute myeloid leukemia.

For patients who wish to purchase from overseas, the price of the Turkish version of the original drug is on the high side. Each box costs more than 10,000 yuan and contains112 100mg tablets. However, there are also generic versions of Venetoclax on the market for patients to choose from. The active ingredients of these generic drugs are roughly the same as those of the original drug. For example, a box of generic drugs produced by a pharmaceutical factory in Laos contains 120 100mg tablets and costs approximately RMB 2,000 (the price may fluctuate due to exchange rates). Compared with original drugs, generic drugs have more advantages in price, providing patients with more economical and affordable treatment options.